Data on this page show the responses of individuals aged 60 years and older who received an adjuvanted or high dose influenza vaccine and completed an AusVaxSafety survey sent in the days following vaccination.  The vaccines currently in use in this age group include Fluad® Quad and Fluzone® High-Dose Quadrivalent. These data provide you with a profile of what to expect in the days following your influenza vaccination and can assist when planning for your influenza vaccination.

 

AusVaxSafety's active vaccine safety surveillance system complements the TGA's enhanced safety surveillance activities.

Links to further information on the influenza vaccines are available below:

Last updated April 2022